Martin Mackay Rallybio Corp (RLYB) insider trading activity

RLYB Quotes by TradingView

Martin Mackay is Executive Chairman of Rallybio Corp. Currently has a direct ownership of 282,609 shares of RLYB, which is worth approximately $268,478. The most recent transaction as insider was on Jan 11, 2022, when has been sold 4,496 shares (Common Stock) at a price of $10.65 per share, resulting in proceeds of $47,882. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 283K
0% 3M change
0% 12M change
Total Value Held $268,478

MARTIN MACKAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2022
BUY
Open market or private purchase
$47,882 $10.65 p/Share
4,496 Added 1.57%
282,609 Common Stock
Jan 10 2022
BUY
Open market or private purchase
$55,590 $10.1 p/Share
5,504 Added 1.94%
278,113 Common Stock
Jul 28 2021
BUY
Other acquisition or disposition
-
272,609 Added 50.0%
272,609 Common Stock

Also insider at

FVAM
5:01 Acquisition Corp. Financial Services
Director
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
SWTX
SpringWorks Therapeutics, Inc. Healthcare
Director
MM

Martin Mackay

Executive Chairman
Wilmington, MA

Track Institutional and Insider Activities on RLYB

Follow Rallybio Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RLYB shares.

Notify only if

Insider Trading

Get notified when an Rallybio Corp insider buys or sells RLYB shares.

Notify only if

News

Receive news related to Rallybio Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RLYB